The PD-8 HERIZON study
Joshua Tobias, affiliated with the Medical University of Vienna, on the PD-8 HERIZON. A phase 2 study of HER-Vaxx, a HER2-targeting peptide vaccine plus SOC chemotherapy in patients with HER2+ advanced stomach cancer.
With the educational support of:
